Key points are not available for this paper at this time.
In our study, intravenous rt-PA treatment was beneficial for patients with mild deficit. Given the observational nature of these results, our data might serve as an incentive for future randomized controlled trials to provide a basis for optimal patient selection.
Greisenegger et al. (Fri,) studied this question.